BrainsWay

A study published by the Journal of Clinical Medicine determined that BrainsWay's proprietary Deep TMS™ treatment is highly effective in treating comorbid #Anxiety in #Depression.

⬇️ Read the full study below: bit.ly/3h81lCT.

Wishing our community a season of warmth and time with loved ones. Thank you for being part of our journey! Happy Holidays from all of us at BrainsWay. ❄️ #HappyHolidays #LookingAhead #HealthcareInnovation

Exciting news! Optum Behavioral Health now covers Deep TMS™ therapy for adolescents 15+ with MDD, benefiting over 48 million! A crucial non-drug option. ow.ly/erJR50XNe2U #MentalHealth #AdolescentDepression #DeepTMS #AccessToCare

📣 Join us for BrainsWay's Virtual Analyst & Investor Day on Dec 1, 2025, at 10 AM ET! Featuring insights from Owen Scott Muir, MD, and Michael Gershenzon. Don't miss the live Q&A! Register Here: lifescievents.com/event/hbg2t9aj/

FDA grants 510(k) clearance for TMS as an adjunctive treatment for Major Depressive Disorder in ages 15–21. Data from 1,100+ patients shows strong safety and symptom improvement. 👉 Read the full Healio article here: healio.com/news/psychiatr…